Ashland/$ASH

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Ashland

Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.

Ticker

$ASH
Sector

Primary listing

NYSE

Industry

Chemicals

Employees

3,200

ISIN

US0441861046

Ashland Metrics

BasicAdvanced
$2.5B
-
-$2.43
0.57
$1.63
3.05%

What the Analysts think about Ashland

Analyst ratings (Buy, Hold, Sell) for Ashland stock.

Bulls say / Bears say

Ashland's upcoming Innovation Day on May 29, 2025, aims to showcase enhanced capabilities and expanded applications of its scalable technology platforms, potentially boosting investor confidence and market position. (stocktitan.net)
The completion of the Avoca business sale to Mane on March 14, 2025, allows Ashland to streamline operations and focus on core competencies, which could lead to improved financial performance. (stocktitan.net)
Ashland's strategic acquisition of a specialty chemicals business is expected to bolster its product portfolio and expand its customer base, enhancing its competitive edge in the specialty chemicals sector. (ainvest.com)
Ashland reported a net loss of $165 million in Q1 fiscal 2025, compared to a net income of $26 million in the prior year, indicating potential financial instability. (stocktitan.net)
The company's adjusted EBITDA declined by 13% year-over-year in Q1 fiscal 2025, primarily due to portfolio optimization, reduced pricing, and increased expenses, which may raise concerns about profitability. (stocktitan.net)
Insider selling, such as the sale of 868 shares by SVP Robin E. Lampkin on November 15, 2024, might signal a lack of confidence in the company's future performance. (insidertrades.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jul 2025.

Ashland Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Ashland Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ASH

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs